2012-09-07 18:19:12 -
Abbott Enters into Licensing and Supply Agreement with Zydus Cadila - Deal Analysis - a new market research report on companiesandmarkets.com
Abbott Enters into Licensing and Supply Agreement with Zydus Cadila - Deal Analysis from GlobalData - The report provides information on the strategic split of Abbott Laboratories into two diversified companies, medical products and research-based pharmaceutical company.
Report Scope
The report is an essential source of information on -
- Analysis on the deal
- Overall rationale of the deal
- Financials
- Company Profile of Abbott Laboratories and Zydus Cadila Healthcare Limited
- Insights on the regulatory and development milestone payments
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- To understand the intention behind the split of Abbott Laboratories
- Strategic implications of the spin-off
- Rationale
behind the deal
Click for report details:
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports
www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.